"Samson Clinical is setting new milestones in the rediscovery of Loniten by developing low dose oral minoxidil."
- Professor Rodney Sinclair - Founder & key opinion Leader
.png)
Samson Clinical
About us
Samson Clinical is an Australian pharmaceutical company, established in 2015 by Professor Rodney Sinclair. Professor Sinclair is Australia’s leading academic and specialist dermatologist, who has researched hair growth for over 30 years and is recognised as one of the world’s foremost hair loss scientists.
We know there are millions of men and women all over the world searching for a scientifically proven hair loss treatment that is safe, simple to use, and grows hair.
Samson has a revolutionary solution: low dose sublingual minoxidil.
About Professor Rodney Sinclair
Samson was founded by Professor Rodney Sinclair, MBBS, MD, FACD, who is a Professor of Medicine at the University of Melbourne and Australia’s highest ranked dermatologist researcher. He has over 30 years’ experience in clinical dermatology and hair research. With over 700 listed publications, 30,000 literature citations and an H-index of 81, he is ranked no. 32 in the world for dermatology research.
Professor Sinclair was awarded a doctorate for his thesis on androgenetic alopecia in 2004 and was a part of the team that identified the first 3 genes involved in androgenetic alopecia. He has published numerous textbooks, research articles and book chapters on hair biology and hair loss treatment.
How it works
Minoxidil is a pro-drug that requires bio-activation within the hair follicle. The active metabolite, minoxidil sulfate, activates dormant telogen follicles, prolongs the anagen growth phase and reverses hair follicle miniaturization. For patients this means less hair loss, stronger and thicker hair fibres, improved hair growth and better scalp hair coverage.
Sublingual delivery bypasses hepatic first-pass metabolism to increase minoxidil sulfate in the hair follicle and hair growth and at the same time reduces minoxidil sulfate in the circulation and avoids haemodynamic side-effects such as palpitations.
Our journey
Professor Sinclair first pioneered the use of low dose minoxidil in 2004, and since 2010 he has used it to treat hair loss in over 20,000 patients in his Melbourne dermatology clinic alone.
In 2015, Samson Clinical developed sublingual minoxidil (SLM) to improve drug delivery, maximise hair growth and improve patient safety. Through R&D we have developed a proprietary, rapid-dissolving SLM with excellent stability and prolonged shelf-life.
The Phase 1 clinical trial was completed in 2024 and the pivotal Phase 3 clinical trial in men with androgenetic alopecia commenced in 2025.
Contact us
News
PROF. RODNEY SINCLAIR
Founder & Key Opinion Leader
Specialist Dermatologist - Professor of Dermatology, University of Melbourne.
Founder of Samson Clinical & Sinclair Dermatology.
Founder & President - Australasian Hair & Wool Research Society.
Honorary Life Member - British Association of Dermatologists.
Honorary Life Member - American Dermatology Association.
Samson team
Professor Rodney Sinclair
Samson was founded by Professor Rodney Sinclair, MBBS, MD, FACD, who is a professor of medicine at the University of Melbourne and Australia’s highest ranked dermatologist researcher. Rod has more than 30 years’ experience in clinical dermatology and hair research. With over 700 listed publications, 30,000 literature citations and an H-index of 81, he's ranked #32 in the world for dermatology research.
Professor Sinclair was awarded a doctorate for his thesis on androgenetic alopecia in 2004 and was a part of the team that identified the first three genes involved in androgenetic alopecia. He has published numerous textbooks and research articles on hair biology and hair loss treatment. His chapters in major dermatology textbooks are used to teach hair disease diagnosis and treatment to dermatologists all over the world.
Timeline
Samson Clinical is setting new milestones in the rediscovery of Loniten by developing low dose oral minoxidil as a treatment for hair loss and then reaching further with our patented, rapid dissolving, sublingual minoxidil tablet.
SAMSON CLINICAL
Have any questions?
Email us at samson@samsonclinical.com
© 2025 by Ceteris Creative.